City
Epaper

SC reserves order on disclosure of COVID-19 vaccine clinical trial data, post-vaccination data

By ANI | Updated: March 23, 2022 00:20 IST

The Supreme Court on Monday reserved its order on a PIL seeking public disclosure of COVID-19 vaccine clinical trial data and post-vaccination data which claimed that it is mandatory and required that the government must publish the data "as per international medical norms".

Open in App

The Supreme Court on Monday reserved its order on a PIL seeking public disclosure of COVID-19 vaccine clinical trial data and post-vaccination data which claimed that it is mandatory and required that the government must publish the data "as per international medical norms".

A bench, headed by Justice L Nageswara Rao, reserved the judgement after hearing arguments from counsels of all the parties.

The plea was filed by Dr Jacob Puliyel alleging coercive vaccination of citizens and seeking disclosure of COVID-19 vaccine clinical trial data and post-vaccination data.

The Central government had earlier filed the affidavit on the plea saying that any "misgivings and misconceived doubts and motivated propaganda" against COVID-19 vaccination can only result in a potential threat of increasing vaccine hesitancy, which will not be in the public interest.

It had said such a plea goes against national interest and would violate the rights of citizens to get vaccinated against the virus.

The affidavit had pointed out that there is a statutory regime in place for trial and approval of vaccines and that the same has been followed.

All vaccination trial data is in public, except the data that would expose any information about the participants of the clinical trial, which is against rules and guidelines, it had added

The plea has raised a false alarm and warning against efforts of the nation to combat an unprecedented tragedy faced by the human race, said the Centre seeking dismissal of the plea.

The PIL sought direction for transparency in clinical trial data for the COVID-19 vaccines being administered in India under emergency use.

Dr Puliyel had also sought a stay on the COVID-19 vaccine mandates that are being issued by authorities in various parts of the country.

He had also said that the Helsinki and World Health Organization (WHO) mandated that all COVID-19 vaccine data and trials have to be in a transparent manner, which, in this case, was not made.

The plea sought direction to the Centre to disclose the reasoned decision of the DCGI granting approval or rejecting an application for emergency use authorization of COVID-19 vaccines and to also disclose the post-vaccination data regarding the adverse impact of vaccines -- who got infected, who needed hospitalization and those who died after such infection post-COVID-19 vaccination.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: indiaHelsinkiSupreme CourtL Nageswara RaoWorld Health OrganizationWhoWorld healthU of u healthFinance and healthIndi
Open in App

Related Stories

BusinessVodafone Idea Shares Jump 3% Today as Telecom Stock Rises 75% in Three Months Amid Strong Market Momentum

BusinessVodafone Idea Shares Rise 2% as Global Brokerage Sees 36% Upside, Maintains ‘Buy’ Rating

BusinessVodafone Idea Share Price Jumps 5% in a Single Day After Strong Q2 Results; Stock Hits ₹10

MumbaiMumbai: 90,000 Stray Dogs, Only 8 Shelters - City Faces Crunch After SC Relocation Order

CricketIndia vs South Africa 2025 Schedule: Full List of Matches, Dates, Venues and Fixtures

National Realted Stories

NationalGaruda 25: IAF to participate in 8th edition of bilateral air exercise with French Air and Space Force

NationalTVK to hold statewide protest in TN today against SIR of electoral rolls

NationalMP: 25 injured in tractor-trolley collision, 7 critical

NationalPM Modi’s leadership getting stronger, Congress fighting for its existence: BJP MP

NationalPM Modi's timeless tribute: From Surat's 2012 spotlight to Bihar's 2025 electoral embrace